Bu, S., Zhang, X., Zhu, H., Shuai, Y., Xing, X., & Yang, W. (2017). Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study. Diabetes Ther.

Bu, Shi, Xuelian Zhang, Haiqing Zhu, Ying Shuai, Xiaoyan Xing, and Wenying Yang. "Which Patients Will Benefit From a Switch in Therapy From Premixed Insulin to Insulin Glargine Plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study." Diabetes Ther 2017.

Bu, Shi, et al. "Which Patients Will Benefit From a Switch in Therapy From Premixed Insulin to Insulin Glargine Plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study." Diabetes Ther 2017.